A PHASE I/II STUDY OF THE SAFETY AND EFFICACY OF TOPICAL 1-(S)-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE DIHYDRATE (CIDOFOVIR; HPMPC) IN THE TREATMENT OF REFRACTORY MUCOCUTANEOUS HERPES SIMPLEX DISEASE IN PATIENTS WITH AIDS: